The most common AEs reported during the study were: Headache (6 times) Fatigue (4) Hypoglycemia unspecified (3) Dizziness (3) Nasopharyngitis (2) Cough (2) Lethargy (1) Tonsillitis (1) Abdominal pain unspecified (1) Application site reaction unspecified (1) Injection site bruising (1) Rhinitis seasonal (1) Anorexia (1) Injection site pain (1) None of the AEs were of severe intensity and there was no observable trend between the different treatment groups with respect to the incidence of certain AEs
Less insulin is needed to manage the same glucose load
Higher growth hormone levels activate hormone-sensitive lipase, which breaks down stored triglycerides in fat cells
However, injections have an important edge over oral supplements that you may not be aware of
Conditions include alcoholic liver disease, viral hepatitis, cirrhosis, and primary or metastatic liver cancer Renal dysfunction : Impaired kidney function reduces B12 elimination, causing accumulation even with normal intake Haematological conditions : Myeloproliferative neoplasms, chronic myeloid leukaemia, polycythaemia vera, and hypereosinophilic syndrome increase transcobalamin production, elevating total serum B12 Laboratory interference : Macro-B12 (immunoglobulin-bound B12) and assay interference can cause spuriously elevated results without true excess In clinical practice, unexplained hypercobalaminaemia should prompt investigation for underlying disease, particularly in patients without obvious supplementation history
